Colgate-Palmolive (NYSE:CL) Position Lessened by HM Payson & Co.

HM Payson & Co. reduced its stake in shares of Colgate-Palmolive (NYSE:CL) by 0.4% in the third quarter, Holdings Channel.com reports. The institutional investor owned 70,091 shares of the company’s stock after selling 274 shares during the period. HM Payson & Co.’s holdings in Colgate-Palmolive were worth $7,276,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently added to or reduced their stakes in the stock. Valeo Financial Advisors LLC grew its holdings in Colgate-Palmolive by 5.1% during the first quarter. Valeo Financial Advisors LLC now owns 11,426 shares of the company’s stock worth $1,029,000 after acquiring an additional 552 shares during the period. Lake Street Private Wealth LLC boosted its position in shares of Colgate-Palmolive by 36.1% in the 1st quarter. Lake Street Private Wealth LLC now owns 4,402 shares of the company’s stock valued at $396,000 after purchasing an additional 1,168 shares during the period. Norden Group LLC purchased a new stake in Colgate-Palmolive in the 1st quarter worth about $532,000. Kovack Advisors Inc. raised its stake in shares of Colgate-Palmolive by 22.3% during the 1st quarter. Kovack Advisors Inc. now owns 4,745 shares of the company’s stock worth $427,000 after purchasing an additional 865 shares in the last quarter. Finally, Diversify Advisory Services LLC acquired a new position in shares of Colgate-Palmolive during the 1st quarter valued at about $911,000. 80.41% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Colgate-Palmolive

In other Colgate-Palmolive news, insider Sally Massey sold 15,850 shares of the business’s stock in a transaction dated Tuesday, August 6th. The stock was sold at an average price of $103.28, for a total transaction of $1,636,988.00. Following the sale, the insider now owns 13,942 shares in the company, valued at approximately $1,439,929.76. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Colgate-Palmolive news, Director Martina Hundmejean sold 2,313 shares of the stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total transaction of $240,228.18. Following the transaction, the director now owns 11,755 shares in the company, valued at approximately $1,220,874.30. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Sally Massey sold 15,850 shares of the stock in a transaction that occurred on Tuesday, August 6th. The shares were sold at an average price of $103.28, for a total value of $1,636,988.00. Following the transaction, the insider now directly owns 13,942 shares of the company’s stock, valued at $1,439,929.76. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 43,490 shares of company stock worth $4,486,063. 0.34% of the stock is currently owned by insiders.

Colgate-Palmolive Stock Up 0.1 %

NYSE:CL traded up $0.11 during mid-day trading on Thursday, hitting $94.77. 199,091 shares of the company’s stock traded hands, compared to its average volume of 4,337,400. The company has a fifty day moving average of $102.69 and a 200 day moving average of $98.17. Colgate-Palmolive has a twelve month low of $73.97 and a twelve month high of $109.30. The company has a market capitalization of $77.43 billion, a P/E ratio of 27.13, a P/E/G ratio of 3.54 and a beta of 0.40. The company has a debt-to-equity ratio of 16.90, a quick ratio of 0.70 and a current ratio of 1.06.

Colgate-Palmolive Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 2.11%. The ex-dividend date of this dividend is Friday, October 18th. Colgate-Palmolive’s dividend payout ratio is currently 57.31%.

Analyst Ratings Changes

CL has been the topic of several recent research reports. Jefferies Financial Group lowered Colgate-Palmolive from a “buy” rating to a “hold” rating and decreased their price objective for the stock from $103.00 to $95.00 in a report on Wednesday, July 24th. Morgan Stanley boosted their target price on Colgate-Palmolive from $103.00 to $111.00 and gave the stock an “overweight” rating in a research report on Monday, July 29th. UBS Group lifted their price objective on Colgate-Palmolive from $119.00 to $122.00 and gave the stock a “buy” rating in a research note on Wednesday, September 4th. JPMorgan Chase & Co. lifted their price objective on Colgate-Palmolive from $113.00 to $114.00 and gave the stock an “overweight” rating in a research note on Friday, October 11th. Finally, HSBC reissued a “hold” rating on shares of Colgate-Palmolive in a research note on Friday, July 26th. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $105.11.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.